Aumovio (AMV0) Pre-close call summary
Event summary combining transcript, slides, and related documents.
Pre-close call summary
13 Apr, 2026Executive summary
Achieved significant transformation progress, strengthened performance culture, and increased agility since listing in September.
Inclusion in the MDAX at the end of December marked a key milestone.
FY 2025 sales are expected in the range of €18.0-19.0bn, with adjusted EBIT margin at the upper end of 2.5%-4.0% guidance.
Free cash flow generation remains a top priority, with ambitions for positive adjusted free cash flow in 2025, even after restructuring and spin-off costs.
Focused on projects contributing positively to midterm profitability and streamlined portfolio through divestments and winding down non-core businesses.
Trading performance and revenue trends
Global light vehicle production rose 1% in Q4, but Europe and North America declined, impacting sales as these regions represent ~75% of group sales.
Global light vehicle production is expected to increase by 4% in FY 2025 compared to FY 2024, with China showing double-digit growth (+10%).
Sales were negatively affected by winding down build-to-print business, contract manufacturing phase-out, divestments, and currency effects from a stronger euro.
Q4 sales development aligns with current guidance for FY2025.
Europe and North America are expected to see slight decreases in vehicle production (-1%).
Profitability and margins
Adjusted EBIT margin for the first nine months was 2.9%; year-end expected at the upper end of 2.5%-4% guidance.
Q4 was seasonally strongest due to customer reimbursements.
Self-help programs continue to drive fixed-cost savings in administration and R&D, supporting mid-term profitability targets.
Tariff impacts remain limited due to high share of USMCA-compliant imports.
Latest events from Aumovio
- Adjusted EBIT up 14.3% YoY to €169m despite 7.8% sales drop; 2026 outlook confirmed.AMV0
Q1 20267 May 2026 - EBIT rose 45% to €717mn despite 5% sales drop, with strong cash flow and liquidity maintained.AMV0
Q4 202518 Mar 2026 - EBIT up 146% on cost savings; 2025 guidance narrowed, margin outlook raised.AMV0
Q3 20257 Nov 2025 - EUR 30.1 million net loss and EUR 29.9 million equity deficit, with IPO-related expenses.AMV0
Q2 202526 Sep 2025